PTCT PTC Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q जुल 30, 2026
$63.46
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$61.2352w निम्न
$90.8752w उच्च
मार्केट कैप (MRQ)
$5.29B
P/E (TTM)
-117.5
EPS (TTM)
$-0.54
राजस्व (TTM)
$1.01B
आपके बैज
52W रेंज
$61–$91
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$102
P/E
-117.5
ROE
20.6%
शुद्ध लाभ मार्जिन
-3.8%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
PTCT स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$63.46
मार्केट कैप (MRQ)
$5.29B
P/E (TTM)
-117.5
EPS (TTM)
$-0.54
राजस्व (TTM)
$1.01B
ROE (TTM)
20.6%
D/E ऋण/इक्विटी (MRQ)
-3.6
52W रेंज
$61–$91
PTCT स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
PTC Therapeutics, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Products
In 2017, PTC acquired Emflaza (deflazacort) from Marathon Pharmaceuticals. PTC also owns Translarna, (Ataluren) marketed for nonsense mutation Duchenne muscular dystrophy. Together, the two products generated revenues of 174 million dollars and 260 million dollars in 2017 and 2018 respectively.
PTC has the commercialization rights for WAYLIVRA (volanesorsen) in Latin America.
In 2018, PTC acquired Agilis Biotherapeutics and a gene therapy candidate, GT-AADC, with its compelling clinical data in treating aromatic L-amino acid decarboxylase (AADC) deficiency. AADC deficiency is a rare CNS disorder arising from reductions in the enzyme AADC that result from mutations in the dopa decarboxylase (DDC) gene. As of 2024, the AAV based treatment for AADC deficiency has been approved by the FDA and commercialized in the United States as Kebilidi. It is the first FDA-approved gene therapy treatment for AADC deficiency. This same product was granted EMA approval for use in the European Union under the name Upstaza.
Pipeline
In 2020, PTC acquired Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases, including phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin (BH4) biochemical pathways diagnosed at birth.
In 2020, PTC announced the FDA approval of Evrysdi (risdiplam) for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older.
In 2024, Novartis has committed $1 billion upfront in a licensing deal with PTC Therapeutics for an experimental treatment for Huntington’s disease, with the potential for an additional $1.9 billion tied to achieving specific development, regulatory, and commercial milestones. PTC Therapeutics’ therapy, known as PTC518, is an oral medication designed to reduce the production of the mutant protein linked to the genetic mutation responsible for the disease. This mutant protein is believed to contribute to neuronal death, driving disease progression. In June, interim data from a Phase 2 trial indicated that PTC518 successfully lowered levels of the mutant protein in both blood and cerebrospinal fluid.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी991
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$1.73B2016-12-31 → 2025-12-31
EPS$7.782019-12-31 → 2025-12-31
फ्री कैश फ्लो$702M2016-12-31 → 2025-12-31
शुद्ध मार्जिन-3.8%2016-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | PTCT | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | -117.55Y औसत ≈-2.7 | ≈-2.7 | · | · | |
| P/S (TTM) | 5.25Y औसत ≈3.8 | ≈3.8 | 55.0 | अल्पमूल्यित | |
| P/B (MRQ) | -32.05Y औसत ≈481.5 | ≈481.5 | · | · | |
| EV / EBITDA (TTM) | 20.25Y औसत ≈-5.5 | ≈-5.5 | · | · | |
| मूल्य / FCF (TTM) | -133.25Y औसत ≈-10.8 | ≈-10.8 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | -173.45Y औसत ≈-12.1 | ≈-12.1 | · | · | |
| EV / राजस्व (TTM) | 3.65Y औसत ≈3.0 | ≈3.0 | · | · | |
| EV / FCF (TTM) | -91.95Y औसत ≈-8.4 | ≈-8.4 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | -9.3 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | PTCT | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 12.5%5Y औसत ≈-25.9% | ≈-25.9% | -24.1% | शीर्ष स्तर | |
| EBITDA मार्जिन (TTM) | 17.9%5Y औसत ≈-13.8% | ≈-13.8% | -24.1% | शीर्ष स्तर | |
| प्रीटैक्स मार्जिन (TTM) | -6.6%5Y औसत ≈-43.8% | ≈-43.8% | -28.9% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | -3.8%5Y औसत ≈-42.4% | ≈-42.4% | -38.1% | शीर्ष स्तर | |
| ROA (TTM) | -1.3%5Y औसत ≈-12.6% | ≈-12.6% | -27.7% | शीर्ष स्तर | |
| ROE (TTM) | 20.6%5Y औसत ≈-299.7% | ≈-299.7% | -40.8% | कमजोर | |
| ROIC | 1044.7%5Y औसत ≈267.1% | ≈267.1% | -37.7% | शीर्ष स्तर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | PTCT | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | -3.65Y औसत ≈74.5 | ≈74.5 | · | · | |
| वर्तमान अनुपात (MRQ) | 3.45Y औसत ≈2.1 | ≈2.1 | 8.3 | कम तरलता | |
| त्वरित अनुपात (MRQ) | 3.25Y औसत ≈2.0 | ≈2.0 | 3.2 | अनुरूप | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | -3.25Y औसत ≈65.1 | ≈65.1 | · | · |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | PTCT | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 114.5%5Y औसत ≈41.2% | ≈41.2% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 35.3%5Y औसत ≈28.3% | ≈28.3% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 35.4% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | PTCT | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.85Y औसत ≈0.5 | ≈0.5 | 0.4 | शीर्ष स्तर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 10.25Y औसत ≈6.8 | ≈6.8 | 9.7 | अनुरूप | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$1.7M | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
105.2%
अगली रिपोर्ट
नव 02, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 5, 2026 | $0.92 | $0.43 | 116.4% |
| 31 मार्च 2026 | $-0.03 | $-0.48 | 93.7% | |
| 31 दिसमबर 2025 | $-1.67 | $0.04 | -4460.3% | |
| 30 सितमबर 2025 | $0.20 | $-1.40 | 114.3% | |
| 30 जून 2025 | $-0.83 | $-1.08 | 23.3% | |
| 31 मार्च 2025 | $10.04 | $-0.22 | 4743.8% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Cost of Revenue | · | · | · | · | · | · | $12M | $13M | $5M | $0 | $0 | · | |
| R&D Expense | $455M | $534M | $667M | $651M | $541M | $478M | $257M | $172M | $117M | $118M | $122M | $80M | |
| SG&A Expense | $347M | $301M | $333M | $326M | $286M | $245M | $203M | $154M | $121M | $97M | $82M | $45M | |
| Operating Expenses | $864M | $1.11B | $1.38B | $1.15B | $913M | $813M | $548M | $380M | $259M | $215M | $204M | $125M | |
| Operating Income | $867M | $-303M | $-440M | $-447M | $-374M | $-432M | $-241M | $-116M | $-64M | $-132M | $-167M | $-99M | |
| Other Non-op | $-18M | $7M | $10M | $-49M | $-58M | $85M | $14M | $129.0K | $-1M | $-1M | $-465.0K | $-213.0K | |
| Pretax Income | $697M | $-363M | $-696M | $-587M | $-518M | $-403M | $-240M | $-128M | $-78M | $-142M | $-170M | $-98M | |
| Income Tax | $14M | $176.0K | $-70M | $-28M | $6M | $35M | $12M | $-29.0K | $1M | $569.0K | $485.0K | $-5M | |
| Net Income | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| EPS (Basic) | $8.58 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | $-2.75 | $-2.02 | · | · | $-2.97 | |
| EPS (Diluted) | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | · | · | · | · | $-2.97 | |
| Shares (Basic) | 79,534,290 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| Shares (Diluted) | 88,311,494 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| EBITDA | $906M | $-227M | $-203M | · | $-310M | $-388M | $-209M | $-90M | $-47M | $-132M | $-167M | $-99M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $985M | $780M | $594M | $280M | $190M | $209M | $288M | $169M | $112M | $58M | $58M | $50M | |
| Short-term Investments | $961M | $360M | $283M | $131M | $584M | $895M | $399M | $58M | $79M | $173M | $281M | $265M | |
| Receivables | $182M | $159M | $161M | $156M | $110M | $70M | $56M | $68M | $40M | $25M | $11M | $4M | |
| Inventory | $80M | $23M | $31M | $22M | $16M | $19M | $19M | $16M | $11M | $0 | · | · | |
| Prepaid Expense | $67M | $44M | $150M | $106M | $55M | $39M | $18M | $9M | $7M | $5M | $6M | $4M | |
| Current Assets | $2.27B | $1.37B | $1.22B | $694M | $954M | $1.23B | $779M | $321M | $249M | $261M | $356M | $324M | |
| PP&E (Net) | $55M | $61M | $87M | $73M | $53M | $34M | $22M | $13M | $8M | $7M | $9M | $9M | |
| PP&E (Gross) | $102M | $94M | $138M | $110M | $80M | $52M | $33M | $20M | $41M | $38M | $37M | $34M | |
| Accum. Depreciation | $47M | $33M | $51M | $37M | $27M | $18M | $12M | $7M | $33M | $31M | $28M | $25M | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $0 | · | · | · | |
| Intangibles | $389M | $119M | $379M | $706M | $725M | $715M | $710M | $701M | $133M | $0 | · | · | |
| Total Assets | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Accounts Payable | $45M | $17M | $6M | $27M | $23M | $19M | $10M | $6M | $15M | $6M | $6M | $4M | |
| Current Liabilities | $968M | $581M | $603M | $406M | $509M | $277M | $236M | $167M | $82M | $50M | $45M | $32M | |
| Capital Leases | $94M | $75M | $98M | $101M | $74M | $79M | $9M | · | · | · | · | · | |
| Deferred Tax | · | · | $56M | $103M | $137M | $137M | $131M | $122M | $0 | · | · | · | |
| Other Non-current Liabilities | $14M | $21M | $141.0K | $3M | · | $1M | $141.0K | $58.0K | $243.0K | $335.0K | $2M | $2M | |
| Total Liabilities | $3.10B | $2.80B | $2.71B | $2.05B | $1.94B | $1.73B | $1.03B | $768M | $235M | $150M | $139M | $35M | |
| Long-term Debt | · | · | · | · | $431M | · | $314M | $153M | $145M | · | · | · | |
| Total Debt | $287M | $285M | $284M | · | $431M | $309M | $314M | $153M | $145M | $98M | $95M | · | |
| Common Stock | $80.0K | $77.0K | $75.0K | $72.0K | $71.0K | $70.0K | $62.0K | $51.0K | $42.0K | $34.0K | $34.0K | $33.0K | |
| Paid-in Capital | $2.75B | $2.57B | $2.47B | $2.31B | $2.12B | $2.17B | $1.80B | $1.29B | $967M | $856M | $820M | $722M | |
| Retained Earnings | $-2.96B | $-3.65B | $-3.28B | $-2.66B | $-2.10B | $-1.63B | $-1.19B | $-939M | $-814M | $-735M | $-593M | $-423M | |
| AOCI | $11M | $-26M | $-1M | $5M | $-24M | $-61M | $-11M | $1M | $4M | $-1M | $-1M | $-737.0K | |
| Stockholders' Equity | $-205M | $-1.10B | $-819M | $-347M | $1M | $482M | $594M | $351M | $156M | $120M | $226M | $298M | |
| Liabilities + Equity | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Shares Outstanding | 81,474,366 | 77,704,188 | 75,708,889 | 73,104,692 | 70,828,226 | 69,718,096 | 61,935,870 | 50,606,147 | 41,612,395 | 34,169,410 | 33,916,559 | 32,898,392 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $39M | $76M | $237M | $129M | $64M | $43M | $32M | $26M | $18M | $3M | $3M | · | |
| Stock-based Comp | $75M | $75M | $102M | $110M | $104M | $70M | $42M | $33M | $31M | $35M | $34M | $19M | |
| Deferred Tax | $-3.0K | $-56M | $-47M | $-34M | $377.0K | $6M | $9M | $0 | $199.0K | $-199.0K | $0 | $0 | |
| Amort. of Intangibles | $25M | $61M | $223M | $117M | $55M | $37M | $28M | $23M | $15M | $0 | $0 | · | |
| Restructuring | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-85M | $161M | $177M | · | $105M | $124M | $70M | $41M | $20M | · | · | · | |
| Operating Cash Flow | $711M | $-108M | $-158M | $-357M | $-251M | $-194M | $-99M | $-28M | $-10M | $-104M | $-124M | $-57M | |
| CapEx | $9M | $7M | $28M | $32M | $28M | $18M | $14M | $7M | $3M | $2M | $3M | $5M | |
| Investing Cash Flow | $-862M | $44M | $-177M | $290M | $219M | $-562M | $-387M | $-43M | $13M | $104M | $-21M | $-145M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | $-49.0K | |
| Stock Issued | · | · | · | · | · | $28M | $324M | $118M | $0 | $0 | $0 | $236M | |
| Net Stock Activity | · | · | · | · | · | $28M | $324M | $118M | · | $0 | · | $236M | |
| Financing Cash Flow | $331M | $256M | $646M | $168M | $21M | $669M | $613M | $132M | $44M | $968.0K | $154M | $237M | |
| Net Change in Cash | $203M | $185M | $314M | $99M | $-19M | $-79M | $126M | $58M | $53M | $299.0K | $8M | $34M | |
| Taxes Paid | $37M | $18M | $14M | $5M | $8M | $26M | $2M | $2M | $1M | $943.0K | $111.0K | $0 | |
| Free Cash Flow | $702M | $-114M | $-187M | · | $-280M | $-212M | $-112M | $-35M | $-13M | $-105M | $-127M | $-62M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 50.1% | -37.5% | -46.9% | · | -69.5% | -113.4% | -78.6% | -43.7% | -33.1% | -159.7% | -454.6% | -393.8% | |
| Net Margin | 39.4% | -45.0% | -66.8% | · | -97.3% | -115.1% | -82.0% | -48.4% | -40.6% | -171.8% | -463.6% | -371.4% | |
| Pretax Margin | 40.2% | -45.0% | -74.2% | · | -96.2% | -105.8% | -78.2% | -48.4% | -40.0% | -171.1% | -462.3% | -390.0% | |
| EBITDA Margin | 52.3% | -28.1% | -21.6% | · | -57.6% | -102.0% | -68.1% | -33.8% | -24.0% | -159.7% | -454.6% | -393.8% | |
| ROA | 29.7% | -20.2% | -34.8% | · | -25.3% | -22.9% | -18.3% | -17.0% | -23.9% | -44.8% | -48.6% | -38.6% | |
| ROE | -331.5% | 33.8% | 84.1% | · | -985.1% | -88.3% | -40.0% | -34.8% | -57.2% | -82.2% | -65.0% | -43.1% | |
| ROIC | 1044.7% | 37.2% | 74.0% | · | -87.4% | -59.4% | -27.8% | -23.0% | -21.7% | -60.9% | -52.3% | -31.7% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | 2.0 | · | 1.9 | 4.4 | 3.3 | 1.9 | 3.0 | 5.3 | 7.8 | 10.0 | |
| Quick Ratio | 2.2 | 2.2 | 1.7 | · | 1.7 | 4.2 | 3.1 | 1.8 | 2.8 | 5.2 | 7.7 | 9.8 | |
| Debt / Equity | -1.4 | -0.3 | -0.3 | · | 300.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · | |
| LT Debt / Equity | · | -0.3 | -0.3 | · | 196.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.4 | 0.5 | · | 0.3 | 0.2 | 0.2 | 0.4 | 0.6 | 0.3 | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | 0.7 | · | 0.9 | · | · | · | |
| Receivables Turnover | 10.2 | 5.1 | 5.9 | · | 6.0 | 6.1 | 5.0 | 4.9 | 6.0 | 4.6 | 4.7 | 9.3 |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.52 | $-14.13 | $-10.81 | · | $0.02 | $6.91 | $9.60 | $6.93 | $3.76 | $3.50 | $6.66 | $9.07 | |
| Revenue / Share | $19.60 | $10.50 | $12.53 | · | $7.64 | · | · | · | · | · | · | $0.80 | |
| Cash Flow / Share | $8.05 | $-1.40 | $-2.12 | · | $-3.57 | · | · | · | · | · | · | $-1.81 | |
| Cash / Share | $12.09 | $10.03 | $7.85 | · | $2.68 | $3.00 | $4.65 | $3.35 | $2.69 | $1.71 | $1.71 | $1.51 | |
| EPS (TTM) | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | $-3.21 | $-3.21 | $-3.21 | $-3.21 | $-2.97 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 114.5% | -14.0% | 34.2% | 29.8% | 41.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.3% | 14.4% | 35.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 35.4% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Net Income TTM | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| Market Cap | $6.19B | $3.51B | $2.09B | · | $2.82B | $4.25B | $2.97B | $1.74B | $694M | $373M | $1.10B | $1.70B | |
| Enterprise Value | $4.53B | $2.65B | $1.49B | · | $2.48B | $3.46B | $2.60B | $1.66B | $648M | $239M | $855M | · | |
| P/E | 9.8 | -9.5 | -3.3 | -4.9 | -5.4 | -9.2 | -11.2 | -10.7 | -5.2 | -3.4 | -10.1 | -17.4 | |
| P/S | 3.6 | 4.3 | 2.2 | · | 5.2 | 11.2 | 9.7 | 6.6 | 3.6 | 4.5 | 29.9 | 67.5 | |
| P/B | -30.1 | -3.2 | -2.5 | · | 1961.8 | 8.8 | 5.0 | 5.0 | 4.4 | 3.1 | 4.9 | 5.7 | |
| P / Cash Flow | 8.7 | -32.6 | -13.2 | · | -11.2 | -21.9 | -30.2 | -62.8 | -69.0 | -3.6 | -8.8 | -29.7 | |
| P / FCF | 8.8 | -30.7 | -11.2 | · | -10.1 | -20.1 | -26.5 | -50.0 | -52.7 | -3.5 | -8.6 | -27.5 | |
| EV / EBITDA | 5.0 | -11.7 | -7.4 | · | -8.0 | -8.9 | -12.5 | -18.6 | -13.9 | -1.8 | -5.1 | · | |
| EV / FCF | 6.5 | -23.2 | -8.0 | · | -8.9 | -16.3 | -23.2 | -47.9 | -49.2 | -2.3 | -6.7 | · | |
| EV / Revenue | 2.6 | 3.3 | 1.6 | · | 4.6 | 9.1 | 8.5 | 6.3 | 3.3 | 2.9 | 23.2 | · | |
| Earnings Yield | 10.2% | -10.5% | -30.4% | -20.4% | -18.6% | -10.9% | -8.9% | -9.3% | -19.2% | -29.4% | -9.9% | -5.7% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $361M | $273M | $165M | $211M | $179M | $1.18B | $213M | $197M | $187M | $210M | $307M | $197M | $214M | $220M | $167M | $217M | |
| R&D Expense | $99M | $101M | $133M | $100M | $113M | $109M | $125M | $161M | $132M | $116M | $121M | $164M | $186M | $195M | $189M | $165M | |
| SG&A Expense | $81M | $86M | $97M | $84M | $85M | $81M | $85M | $73M | $70M | $73M | $76M | $81M | $88M | $87M | $93M | $80M | |
| Operating Expenses | $212M | $228M | $236M | $208M | $214M | $206M | $376M | $251M | $227M | $256M | $301M | $315M | $423M | $338M | $368M | $285M | |
| Operating Income | $149M | $45M | $-71M | $3M | $-35M | $970M | $-162M | $-55M | $-40M | $-45M | $6M | $-118M | $-210M | $-118M | $-200M | $-68M | |
| Other Non-op | $-3M | $2M | $-13M | $7M | $-6M | $-6M | $9M | $-2M | $-2M | $2M | $19M | $-20M | $1M | $10M | $35M | $-38M | |
| Pretax Income | $98M | $-2M | $-139M | $-23M | $-71M | $930M | $-95M | $-98M | $-86M | $-85M | $-157M | $-167M | $-237M | $-135M | $-190M | $-127M | |
| Income Tax | $14M | $347.0K | $-4M | $-39M | $-6M | $63M | $-29M | $9M | $13M | $7M | $-1M | $-34M | $-39M | $4M | $-19M | $-18M | |
| Net Income | $83M | $-3M | $-135M | $16M | $-65M | $867M | $-66M | $-107M | $-99M | $-92M | $-156M | $-133M | $-199M | $-139M | $-171M | $-109M | |
| EPS (Basic) | $1.01 | $-0.03 | $-1.88 | $0.20 | $-0.83 | $11.09 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| EPS (Diluted) | $0.92 | $-0.03 | $-1.63 | $0.20 | $-0.83 | $10.04 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| Shares (Basic) | 83,006,808 | 82,521,023 | · | 78,471,119 | 78,151,240 | 78,115,836 | · | 76,925,523 | 76,725,070 | 76,496,127 | · | 75,377,997 | 74,730,433 | 73,729,284 | · | 71,654,671 | |
| Shares (Diluted) | 92,020,009 | 82,521,023 | · | 87,115,369 | 78,151,240 | 86,385,922 | · | 76,925,523 | 76,725,070 | 76,496,127 | · | 75,377,997 | 74,730,433 | 73,729,284 | · | 71,654,671 | |
| EBITDA | $149M | $60M | · | $3M | $-35M | $977M | · | $-55M | $-40M | $10M | · | $-118M | $-210M | $-75M | · | $-68M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.05B | $834M | $985M | $673M | $1.02B | $1.48B | $780M | $526M | $655M | $548M | · | $165M | $208M | $167M | · | $104M | |
| Short-term Investments | $1.18B | $1.06B | $961M | $1.02B | $972M | $547M | $360M | $487M | $439M | $336M | · | $130M | $130M | $119M | · | $184M | |
| Receivables | $239M | $220M | $182M | $203M | $196M | $210M | $159M | $200M | $187M | $198M | · | $166M | $178M | $202M | · | $124M | |
| Inventory | $91M | $76M | $80M | $53M | $34M | $22M | $23M | $36M | $32M | $30M | · | $36M | $32M | $27M | · | $15M | |
| Prepaid Expense | $58M | $66M | $67M | $64M | $54M | $57M | $44M | $33M | $46M | $56M | · | $44M | $42M | $99M | · | $90M | |
| Current Assets | $2.62B | $2.25B | $2.27B | $2.01B | $2.27B | $2.32B | $1.37B | $1.28B | $1.36B | $1.17B | · | $540M | $590M | $613M | · | $517M | |
| PP&E (Net) | $51M | $53M | $55M | $57M | $57M | $59M | $61M | $63M | $66M | $93M | · | $85M | $82M | $79M | · | $67M | |
| PP&E (Gross) | · | · | $102M | · | · | · | $94M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | · | $82M | $82M | $82M | · | $82M | |
| Intangibles | $403M | $381M | $389M | $396M | $144M | $118M | $119M | $330M | $330M | $330M | · | $423M | $452M | $686M | · | $750M | |
| Total Assets | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Accounts Payable | $40M | $25M | $45M | $37M | $27M | $15M | $17M | $13M | $24M | $27M | · | $19M | $26M | $26M | · | $21M | |
| Current Liabilities | $771M | $924M | $968M | $866M | $628M | $595M | $581M | $611M | $610M | $575M | · | $492M | $476M | $442M | · | $420M | |
| Capital Leases | $88M | $90M | $94M | $95M | $71M | $74M | $75M | $83M | $79M | $105M | · | $100M | $100M | $100M | · | $102M | |
| Deferred Tax | · | · | · | · | · | · | · | $56M | $56M | $56M | · | $52M | $52M | $103M | · | $137M | |
| Other Non-current Liabilities | $15M | $14M | $14M | $3M | $8M | $22M | $21M | $77.0K | $141.0K | $141.0K | · | $141.0K | $141.0K | $141.0K | · | $5M | |
| Total Liabilities | $3.42B | $3.05B | $3.10B | $2.80B | $2.84B | $2.84B | $2.80B | $2.90B | $2.90B | $2.68B | · | $1.93B | $1.92B | $2.07B | · | $1.80B | |
| Long-term Debt | $591M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $591M | $287M | · | $286M | $286M | $286M | · | $285M | $285M | $285M | · | $573M | $573M | $572M | · | $283M | |
| Common Stock | $82.0K | $81.0K | $80.0K | $79.0K | $78.0K | $78.0K | $77.0K | $76.0K | $76.0K | $76.0K | · | $75.0K | $75.0K | $73.0K | · | $71.0K | |
| Paid-in Capital | $2.71B | $2.78B | $2.75B | $2.67B | $2.63B | $2.61B | $2.57B | $2.53B | $2.51B | $2.49B | · | $2.45B | $2.42B | $2.34B | · | $2.22B | |
| Retained Earnings | $-2.88B | $-2.97B | $-2.96B | $-2.83B | $-2.85B | $-2.78B | $-3.65B | $-3.58B | $-3.47B | $-3.38B | · | $-3.13B | $-2.99B | $-2.80B | · | $-2.49B | |
| AOCI | $6M | $8M | $11M | $6M | $7M | $-14M | $-26M | $-4M | $-16M | $-6M | · | $10M | $-1M | $-2M | · | $36M | |
| Stockholders' Equity | $-165M | $-180M | $-205M | $-156M | $-207M | $-186M | $-1.10B | $-1.05B | $-980M | $-894M | $-819M | $-671M | $-579M | $-458M | $-347M | $-227M | |
| Liabilities + Equity | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Shares Outstanding | 83,327,286 | 82,882,024 | 81,474,366 | 79,931,766 | 79,378,145 | 79,225,276 | 77,704,188 | 76,952,124 | 76,900,123 | 76,653,960 | · | 75,459,022 | 75,318,233 | 74,012,034 | · | 71,854,892 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $13M | $11M | $8M | $7M | $7M | $6M | $7M | $55M | $81M | $62M | $51M | $43M | $39M | $34M | |
| Stock-based Comp | $23M | $23M | $19M | $19M | $19M | $18M | $17M | $20M | $19M | $18M | $17M | $27M | $29M | $29M | $27M | $29M | |
| Deferred Tax | · | $-10.0K | $1.0K | · | · | $2.0K | $-56M | $-3.0K | $2.0K | $-1.0K | $4M | $-2.0K | $-51M | $-4.0K | · | · | |
| Amort. of Intangibles | $12M | $12M | $9M | $8M | $4M | $4M | $3M | $3M | $3M | $52M | $77M | $59M | $47M | $39M | $36M | $31M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $23M | $8M | · | · | · | |
| Other Non-cash | · | $-95M | · | · | · | $-22M | · | · | · | $89M | · | · | · | $38M | · | · | |
| Operating Cash Flow | $129M | $-59M | $-34M | $-66M | $-58M | $870M | $-30M | $-77M | $-71M | $71M | $-100M | $-15M | $-14M | $-29M | $-166M | $-38M | |
| CapEx | $2M | $1M | $2M | $3M | $1M | $2M | $4M | $522.0K | $-7M | $10M | $6M | $6M | $6M | $10M | $9M | $5M | |
| Investing Cash Flow | $-123M | $-94M | $34M | $-290M | $-422M | $-184M | $268M | $-43M | $-66M | $-115M | $-94M | $-30M | $-24M | $-29M | $32M | $136M | |
| Financing Cash Flow | $212M | $6M | $303M | $15M | $4M | $9M | $26M | $-18M | $246M | $540.0K | $620M | $3M | $18M | $4M | $303M | $-140M | |
| Net Change in Cash | $216M | $-148M | $312M | $-347M | $-463M | $701M | $256M | $-129M | $104M | $-46M | $429M | $-43M | $-9M | $-62M | $175M | $-54M | |
| Taxes Paid | · | · | $-3M | $936.0K | $36M | $3M | $5M | $7M | $4M | $2M | $524.0K | $4M | $7M | $2M | $893.0K | $1M | |
| Free Cash Flow | · | $-60M | · | · | · | $868M | · | · | · | $61M | · | · | · | $-40M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.3% | 16.5% | · | 1.4% | -19.5% | 82.5% | · | -27.7% | -21.5% | -21.6% | · | -60.1% | -98.0% | -53.4% | · | -31.4% | |
| Net Margin | 23.2% | -1.0% | · | 7.5% | -36.2% | 73.7% | · | -54.2% | -53.1% | -43.6% | · | -67.6% | -93.0% | -63.0% | · | -50.3% | |
| Pretax Margin | 27.1% | -0.90% | · | -10.9% | -39.7% | 79.1% | · | -49.8% | -45.9% | -40.3% | · | -84.8% | -111.1% | -61.3% | · | -58.6% | |
| EBITDA Margin | 41.3% | 22.1% | · | 1.4% | -19.5% | 83.1% | · | -27.7% | -21.5% | 4.7% | · | -60.1% | -98.0% | -33.9% | · | -31.4% | |
| ROA | 2.8% | -0.10% | · | 0.71% | -2.9% | 39.0% | · | -6.9% | -6.1% | -5.4% | · | -9.4% | -12.7% | -8.2% | · | -6.1% | |
| ROE | -44.9% | 1.5% | · | -2.6% | 10.9% | -160.5% | · | 12.4% | 12.7% | 13.6% | · | 29.6% | 52.2% | 50.7% | · | 179.2% | |
| ROIC | 30.0% | 48.2% | · | -1.6% | -40.2% | 904.6% | · | 7.7% | 6.7% | 8.1% | · | 96.6% | 2648.9% | -105.7% | · | -104.9% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.4 | · | 2.3 | 3.6 | 3.9 | · | 2.1 | 2.2 | 2.0 | · | 1.1 | 1.2 | 1.4 | · | 1.2 | |
| Quick Ratio | 3.2 | 2.3 | · | 2.2 | 3.5 | 3.8 | · | 2.0 | 2.1 | 1.9 | · | 0.9 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | -3.6 | -1.6 | · | -1.8 | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 | |
| LT Debt / Equity | -3.2 | · | · | · | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.5 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.7 | 1.3 | · | 1.0 | 0.9 | 5.8 | · | 1.1 | 1.0 | 1.1 | · | 1.4 | 1.4 | 1.3 | · | 2.0 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.98 | $-2.18 | · | $-1.95 | $-2.60 | $-2.34 | · | $-13.70 | $-12.75 | $-11.66 | · | $-8.89 | $-7.69 | $-6.18 | · | $-3.16 | |
| Revenue / Share | $3.92 | $3.30 | · | $2.42 | $2.29 | $13.61 | · | $2.56 | $2.43 | $2.75 | · | $2.61 | $2.86 | $2.99 | · | $3.03 | |
| Cash Flow / Share | · | $-0.72 | · | · | · | $10.07 | · | · | · | $0.93 | · | · | · | $-0.40 | · | · | |
| Cash / Share | $12.60 | $10.06 | · | $8.41 | $12.82 | $18.68 | · | $6.84 | $8.51 | $7.15 | · | $2.19 | $2.77 | $2.26 | · | $1.45 | |
| EPS (TTM) | $-0.54 | $-2.29 | · | $8.56 | $6.97 | $6.51 | · | $-5.95 | $-6.32 | $-7.69 | · | $-8.65 | $-8.42 | $-7.89 | · | $-7.47 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.01B | $827M | · | $1.78B | $1.76B | $1.77B | · | $901M | $900M | $928M | · | $798M | $819M | $770M | · | $697M | |
| Net Income TTM | $-38M | $-187M | · | $752M | $629M | $595M | · | $-453M | $-480M | $-579M | · | $-642M | $-618M | $-571M | · | $-531M | |
| Market Cap | $6.80B | $5.65B | · | $4.91B | $3.88B | $4.04B | · | $2.85B | $2.35B | $2.23B | · | $1.69B | $3.06B | $3.59B | · | $3.61B | |
| Enterprise Value | $5.16B | $4.04B | · | $3.50B | $2.17B | $2.30B | · | $2.13B | $1.54B | $1.63B | · | $1.97B | $3.30B | $3.87B | · | $3.60B | |
| P/E | -151.1 | -29.8 | · | 7.2 | 7.0 | 7.8 | · | -6.2 | -4.8 | -3.8 | · | -2.6 | -4.8 | -6.1 | · | -6.7 | |
| P/S | 6.7 | 6.8 | · | 2.8 | 2.2 | 2.3 | · | 3.2 | 2.6 | 2.4 | · | 2.1 | 3.7 | 4.7 | · | 5.2 | |
| P/B | -41.1 | -31.3 | · | -31.5 | -18.8 | -21.7 | · | -2.7 | -2.4 | -2.5 | · | -2.5 | -5.3 | -7.8 | · | -15.9 | |
| P / Cash Flow | · | -95.6 | · | · | · | 4.6 | · | · | · | 31.5 | · | · | · | -121.6 | · | · | |
| EV / Revenue | 5.1 | 4.9 | · | 2.0 | 1.2 | 1.3 | · | 2.4 | 1.7 | 1.8 | · | 2.5 | 4.0 | 5.0 | · | 5.2 | |
| Earnings Yield | -0.66% | -3.4% | · | 14.0% | 14.3% | 12.8% | · | -16.0% | -20.7% | -26.4% | · | -38.6% | -20.7% | -16.3% | · | -14.9% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $1.73B | $807M | $938M | $699M | $539M |
| परिचालन मार्जिन % | 50.1% | -37.5% | -46.9% | · | -69.5% |
| शुद्ध आय | $683M | $-363M | $-627M | $-559M | $-524M |
| तनुकरणित EPS | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | -1.4 | -0.3 | -0.3 | · | 300.0 |
| वर्तमान अनुपात | 2.3 | 2.4 | 2.0 | · | 1.9 |
| त्वरित अनुपात | 2.2 | 2.2 | 1.7 | · | 1.7 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $702M | $-114M | $-187M | · | $-280M |
संस्थागत मालिक (13F) 403 फाइलर्स · $8.6B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
403
धारित मूल्य
$8.6B
नई स्थितियाँ
76
बाहर निकली पोजीशन
43
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 76 (+7 पिछली तिमाही की तुलना में) | 43 (-7 पिछली तिमाही की तुलना में) | 140 (+3 पिछली तिमाही की तुलना में) | 114 (+10 पिछली तिमाही की तुलना में) | -1.4M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BlackRock, Inc. | $1139088671 | 13964554 | 13.21% | शेयर |
| VANGUARD GROUP INC | $668691300 | 8803203 | 7.75% | शेयर |
| RTW INVESTMENTS, LP | $631875072 | 7746415 | 7.33% | शेयर |
| JANUS HENDERSON GROUP PLC | $489997100 | 7193433 | 5.68% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $401986014 | 4928111 | 4.66% | शेयर |
| STATE STREET CORP | $375136515 | 4598952 | 4.35% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $336743228 | 4128273 | 3.90% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $305000589 | 3739127 | 3.54% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $180089116 | 2207376 | 2.09% | शेयर |
| TORONTO DOMINION BANK | $176668031 | 2165846 | 2.05% | शेयर |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $159563645 | 1956156 | 1.85% | शेयर |
| Hood River Capital Management LLC | $141818662 | 1738613 | 1.64% | शेयर |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $140519660 | 1722688 | 1.63% | शेयर |
| D. E. Shaw & Co., Inc. | $126345323 | 1548919 | 1.47% | शेयर |
| TANG CAPITAL MANAGEMENT LLC | $122355000 | 1500000 | 1.42% | शेयर |
| BANK OF AMERICA CORP /DE/ | $118462234 | 1452277 | 1.37% | शेयर |
| Driehaus Capital Management LLC | $117469528 | 1440107 | 1.36% | शेयर |
| FMR LLC | $114056206 | 1398261 | 1.32% | शेयर |
| Jefferies Financial Group Inc. | $110693916 | 1357042 | 1.28% | शेयर |
| FULLER & THALER ASSET MANAGEMENT, INC. | $94361749 | 1156819 | 1.09% | शेयर |
| Pictet Asset Management Holding SA | $93629635 | 1147844 | 1.09% | शेयर |
| MORGAN STANLEY | $90026886 | 1103675 | 1.04% | शेयर |
| ARMISTICE CAPITAL, LLC | $87393690 | 1071395 | 1.01% | शेयर |
| Blue Sparrow, LLC /DE | $85705599 | 1050700 | 0.99% | शेयर |
| FRANKLIN RESOURCES INC | $83799082 | 1027327 | 0.97% | शेयर |
| Invesco Ltd. | $76804761 | 941581 | 0.89% | शेयर |
| Palo Alto Investors LP | $74950268 | 918846 | 0.87% | शेयर |
| NORTHERN TRUST CORP | $71783966 | 880029 | 0.83% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $64449436 | 790112 | 0.75% | शेयर |
| CITADEL ADVISORS LLC | $60999840 | 747822 | 0.71% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $59015895 | 723500 | 0.68% | शेयर |
| Boston Partners | $58606553 | 718574 | 0.68% | शेयर |
| JUPITER ASSET MANAGEMENT LTD | $57706697 | 707450 | 0.67% | शेयर |
| MARSHALL WACE, LLP | $57489476 | 704787 | 0.67% | शेयर |
| JPMORGAN CHASE & CO | $56073502 | 684042 | 0.65% | शेयर |
| ARMISTICE CAPITAL, LLC | $53836200 | 660000 | 0.62% | कॉल ऑप्शन |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $53377940 | 654382 | 0.62% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $52017434 | 637704 | 0.60% | शेयर |
| GOLDMAN SACHS GROUP INC | $50430408 | 618247 | 0.58% | शेयर |
| LOOMIS SAYLES & CO L P | $48156807 | 590374 | 0.56% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $47953943 | 587887 | 0.56% | शेयर |
| Nuveen, LLC | $47622931 | 583829 | 0.55% | शेयर |
| Bank of New York Mellon Corp | $45145865 | 553462 | 0.52% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $44181166 | 541635 | 0.51% | शेयर |
| VOYA INVESTMENT MANAGEMENT LLC | $43992251 | 539319 | 0.51% | शेयर |
| Ensign Peak Advisors, Inc | $41442128 | 508056 | 0.48% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $40866277 | 500995 | 0.47% | शेयर |
| FEDERATED HERMES, INC. | $39432896 | 483424 | 0.46% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $36050432 | 441957 | 0.42% | शेयर |
| Parkman Healthcare Partners LLC | $35539315 | 435691 | 0.41% | शेयर |
कार्यकर्ता और 5%+ मालिक 3 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Brookside Capital Partners Fund, L.P., Brookside Capital Trading Fund, L.P. ×5 फाइलिंग | 30 जनवरी 2015 | · | प्रारंभिक फाइलिंग | · | SEC |
| HBM Healthcare Investments (Cayman) Ltd. (“HBM”) ×2 फाइलिंग | 12 नवमबर 2014 | · | प्रारंभिक फाइलिंग | · | SEC |
| HBM Healthcare Investments (Cayman) Ltd. | 5 जुलाई 2013 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 37 इनसाइडर्स · 15 अधिकारी · 20 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 4 अगस्त 2026 S | 383868 | 0 | 13 | $-4219888 |
| Stuart Walter Peltz | CHIEF EXECUTIVE OFFICER | 31 जनवरी 2023 S | 54903 | 0 | 0 | $0 |
| Pierre Gravier | CHIEF FINANCIAL OFFICER | 14 जुलाई 2026 S | 83986 | 0 | 3 | $-652864 |
| Emily Luisa Hill | CHIEF FINANCIAL OFFICER | 27 मार्च 2023 S | 38925 | 0 | 0 | $0 |
| Shane William Charles Kovacs | Chief Financial Officer | 9 मई 2017 M | 37850 | 0 | 0 | $0 |
| Claudia De Oliveira Ribeiro Hirawat | President | 15 जनवरी 2015 M | 39247 | 0 | 0 | $0 |
| Marcio Souza | Chief Operating Officer | 10 फ़रवरी 2020 M | 6744 | 0 | 0 | $0 |
| Mark Elliott Boulding | EXEC. VP AND CLO | 17 अगस्त 2026 M | 105272 | 0 | 63 | $-5955553 |
| Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 9 जुलाई 2026 M | 60299 | 0 | 62 | $-25989291 |
| Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 17 जून 2026 M | 70199 | 0 | 5 | $-1941426 |
| Eric Pauwels | CHIEF BUSINESS OFFICER | 10 जून 2026 S | 73411 | 0 | 28 | $-7477160 |
| Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 2 अप्रैल 2026 S | 79115 | 0 | 6 | $-1081515 |
| Mark Rothera | Chief Commercial Officer | 24 मई 2017 M | 33739 | 0 | 0 | $0 |
| Tuyen Ong | Chief Medical Officer | 3 जनवरी 2017 A | 6000 | 0 | 0 | $0 |
| Robert J. Spiegel | Chief Medical Officer | 4 जनवरी 2016 A | 3239 | 0 | 0 | $0 |
| Glenn Steele JR MD PHD | निदेशक | 30 सितमबर 2026 M | 22500 | 0 | 2 | $-1698120 |
| Michael Schmertzler | निदेशक | 17 सितमबर 2026 S | 1296594 | 0 | 16 | $-6313453 |
| Hege Elisabeth Sollie-Zetlmayer | निदेशक | 28 जुलाई 2026 A | 52526 | 0 | 0 | $0 |
| Mary L. Smith | निदेशक | 9 जुलाई 2026 M | 21813 | 0 | 2 | $-1425060 |
| Jessica Caroline Chutter | निदेशक | 24 मार्च 2026 A | 7333 | 0 | 0 | $0 |
| Stephanie Okey | निदेशक | 10 मार्च 2026 M | 8000 | 0 | 3 | $-1463076 |
| Emma Reeve | निदेशक | 5 जनवरी 2026 M | 10666 | 0 | 15 | $-4229530 |
| Alethia Young | निदेशक | 2 जनवरी 2026 A | 21067 | 0 | 0 | $0 |
| Allan Steven Jacobson | निदेशक | 2 जनवरी 2026 A | 21451 | 0 | 11 | $-2912018 |
| Jerome B Zeldis | निदेशक | 2 जनवरी 2026 A | 22500 | 0 | 0 | $0 |
| William F. Bell Jr. | निदेशक | 15 फ़रवरी 2024 A | 10333 | 0 | 0 | $0 |
| Dawn Svoronos | निदेशक | 9 जून 2022 S | 29017 | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | निदेशक | 3 जनवरी 2017 A | · | 0 | 0 | $0 |
| Adam Koppel | निदेशक | 3 जनवरी 2017 A | 2333333 | 0 | 0 | $0 |
| Ronald C Renaud JR | निदेशक | 3 जनवरी 2017 A | · | 0 | 0 | $0 |
| Richard Aldrich | निदेशक | 8 जून 2015 M | 0 | 0 | 0 | $0 |
| Michael L Kranda | निदेशक | 16 मार्च 2015 S | 2242 | 0 | 0 | $0 |
| Axel Bolte | निदेशक | 25 जून 2013 P | 20000 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% मालिक | 17 दिसमबर 2013 S | 2441504 | 0 | 0 | $0 |
| David P Southwell | · | 2 जनवरी 2026 A | 20850 | 0 | 0 | $0 |
| Complete Pharma Holdings II, LLC | · | 28 अप्रैल 2017 J | 0 | 0 | 0 | $0 |
| CREDIT SUISSE/ | · | 25 जून 2013 C | 2256882 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 68 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IBRN · iShares Trust | 3.74% | 4145 SH | 11 सितमबर 2026 | दैनिक |
| PSCH · Invesco Exchange-Traded Fund Trust … | 2.93% | 79357 SH | 2 अक्टूबर 2026 | दैनिक |
| PBE · Invesco Exchange-Traded Fund Trust | 2.47% | 159717 SH | 2 अक्टूबर 2026 | दैनिक |
| MEDI · Harbor ETF Trust | 1.31% | 7913 NS | 31 जुलाई 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1.25% | 18062 NS | 31 जुलाई 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1.23% | 22852 SH | 2 अक्टूबर 2026 | दैनिक |
| JSML · Janus Detroit Street Trust | 1.03% | 54825 NS | 31 जुलाई 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0.94% | 145033 NS | 31 जुलाई 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.74% | 98733 SH | 19 अगस्त 2026 | दैनिक |
| VAMO · Cambria ETF Trust | 0.72% | 11494 NS | 31 जुलाई 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 0.71% | 5120 NS | 31 जुलाई 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.63% | 46006 NS | 31 जुलाई 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.49% | 658 NS | 31 जुलाई 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0.42% | 3031 NS | 31 जुलाई 2026 | N-PORT |
| IBB · iShares Trust | 0.40% | 613266 SH | 11 सितमबर 2026 | दैनिक |
| BRNY · EA Series Trust | 0.39% | 33006 NS | 31 जुलाई 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.37% | 290018 SH | 19 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.36% | 5891 SH | 2 अक्टूबर 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.34% | 75795 SH | 19 अगस्त 2026 | दैनिक |
| ESSC · Strategy Shares | 0.34% | 1785 NS | 31 जुलाई 2026 | N-PORT |
| IWO · iShares Trust | 0.31% | 664357 SH | 11 सितमबर 2026 | दैनिक |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.27% | 22505 NS | 31 जुलाई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.25% | 25676 NS | 31 जुलाई 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.24% | 3125 NS | 31 जुलाई 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.20% | 477030 SH | 19 अगस्त 2026 | दैनिक |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 19797 NS | 31 जुलाई 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.19% | 3667 NS | 31 जुलाई 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.19% | 1099640 SH | 19 अगस्त 2026 | दैनिक |
| IWM · iShares Trust | 0.18% | 2118779 SH | 11 सितमबर 2026 | दैनिक |
| RSSL · Global X Funds | 0.18% | 39691 NS | 31 जुलाई 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.18% | 629 NS | 31 जुलाई 2026 | N-PORT |
| ISCG · iShares Trust | 0.16% | 23005 SH | 11 सितमबर 2026 | दैनिक |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.16% | 65468 SH | 2 अक्टूबर 2026 | दैनिक |
| LRGF · iShares Trust | 0.16% | 84774 SH | 11 सितमबर 2026 | दैनिक |
| VFMO · VANGUARD WELLINGTON FUND | 0.14% | 35428 SH | 19 अगस्त 2026 | दैनिक |
| FSMD · FIDELITY COVINGTON TRUST | 0.14% | 51459 NS | 31 जुलाई 2026 | N-PORT |
| FHEQ · Fidelity Greenwood Street Trust | 0.14% | 18636 NS | 31 जुलाई 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.13% | 5320 SH | 2 अक्टूबर 2026 | दैनिक |
| FBUF · Fidelity Greenwood Street Trust | 0.12% | 413 NS | 31 जुलाई 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0.11% | 3600 NS | 31 जुलाई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.10% | 224327 NS | 31 जुलाई 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.08% | 952071 SH | 19 अगस्त 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.08% | 1902509 SH | 19 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.08% | 211842 SH | 19 अगस्त 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.08% | 6756 NS | 31 जुलाई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.07% | 33487 NS | 31 जुलाई 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.06% | 12627 NS | 31 जुलाई 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.06% | 18932 SH | 2 अक्टूबर 2026 | दैनिक |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.06% | 10557 SH | 19 अगस्त 2026 | दैनिक |
| ESML · iShares Trust | 0.06% | 22893 SH | 11 सितमबर 2026 | दैनिक |
| WSML · iShares Trust | 0.04% | 4360 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.01% | 4108 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 2636335 SH | 19 अगस्त 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 66405 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 6819 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.01% | 18275 SH | 19 अगस्त 2026 | दैनिक |
| ITOT · iShares Trust | 0.01% | 109219 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.01% | 22686 SH | 10 सितमबर 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.01% | 43296 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1090 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 284 NS | 31 जुलाई 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 249 NS | 31 जुलाई 2026 | N-PORT |
| IJR · iShares Trust | · | 5061986 SH | 10 सितमबर 2026 | दैनिक |
| IJT · iShares Trust | · | 784746 SH | 9 सितमबर 2026 | दैनिक |
| IWN · iShares Trust | · | 114658 SH | 11 सितमबर 2026 | दैनिक |
| XJR · iShares Trust | · | 11464 SH | 31 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | · | 3281 SH | 11 सितमबर 2026 | दैनिक |
| SMLF · iShares Trust | · | 64380 SH | 11 सितमबर 2026 | दैनिक |
PTCT विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 21 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$101.00
+59.2%
6 28.6%
मजबूत खरीद
11 52.4%
खरीदें
3 14.3%
होल्ड
1 4.8%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
14 विश्लेषक · 2026-10-01माध्य लक्ष्य $101.79 +60.4%
← सभी लक्ष्यों से नीचे
वर्तमान मूल्य $63.46
निम्न$70.00
माध्य$101.79
उच्च$137.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q जुल 30, 2026 को फाइल किया गया